Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual Meeting
April 11, 2023 08:03 ET
|
Zai Lab Limited
SHANGHAI and CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will present new data including a translational and biomarker data analysis from its...
Diaccurate présentera des données actualisées de son nouvel inhibiteur de la voie PAM DIACC3010 dans le cancer du sein métastatique ER+ HER2- à l’AACR 2023
April 06, 2023 08:30 ET
|
DIACCURATE
Diaccurate présentera des données actualisées de son nouvel inhibiteur de la voie PAM DIACC3010 dans le cancer du sein métastatique ER+ HER2- à l’AACR 2023 DIACC3010 a une excellente activité...
Diaccurate Announces Updated Data on its Novel PAM Pathway Inhibitor DIACC3010 in Patients with ER+ HER2- Metastatic Breast Cancer to be Presented at AACR 2023
April 06, 2023 08:30 ET
|
DIACCURATE
Diaccurate Announces Updated Data on its Novel PAM Pathway Inhibitor DIACC3010 in Patients with ER+ HER2- Metastatic Breast Cancer to be Presented at AACR 2023 DIACC3010 displays broad efficacy in...
Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR Meeting
March 14, 2023 16:35 ET
|
Senti Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies using...